These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25712333)

  • 1. Economic evaluation of typhoid vaccination in a prolonged typhoid outbreak setting: the case of Kasese district in Uganda.
    Carias C; Walters MS; Wefula E; Date KA; Swerdlow DL; Vijayaraghavan M; Mintz E
    Vaccine; 2015 Apr; 33(17):2079-85. PubMed ID: 25712333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries.
    Cook J; Jeuland M; Whittington D; Poulos C; Clemens J; Sur D; Anh DD; Agtini M; Bhutta Z;
    Vaccine; 2008 Nov; 26(50):6305-16. PubMed ID: 18835415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study.
    Bilcke J; Antillón M; Pieters Z; Kuylen E; Abboud L; Neuzil KM; Pollard AJ; Paltiel AD; Pitzer VE
    Lancet Infect Dis; 2019 Jul; 19(7):728-739. PubMed ID: 31130329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting: a modeling study.
    Phillips MT; Antillon M; Bilcke J; Bar-Zeev N; Limani F; Debellut F; Pecenka C; Neuzil KM; Gordon MA; Thindwa D; Paltiel AD; Yaesoubi R; Pitzer VE
    BMC Infect Dis; 2023 Mar; 23(1):143. PubMed ID: 36890448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of typhoid fever transmission dynamic models and economic evaluations of vaccination.
    Watson CH; Edmunds WJ
    Vaccine; 2015 Jun; 33 Suppl 3(Suppl 3):C42-54. PubMed ID: 25921288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings.
    Antillón M; Bilcke J; Paltiel AD; Pitzer VE
    Vaccine; 2017 Jun; 35(27):3506-3514. PubMed ID: 28527687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of model predictions of typhoid conjugate vaccine public health impact and cost-effectiveness.
    Burrows H; Antillón M; Gauld JS; Kim JH; Mogasale V; Ryckman T; Andrews JR; Lo NC; Pitzer VE
    Vaccine; 2023 Jan; 41(4):965-975. PubMed ID: 36586741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shifts in geographic distribution and antimicrobial resistance during a prolonged typhoid fever outbreak--Bundibugyo and Kasese Districts, Uganda, 2009-2011.
    Walters MS; Routh J; Mikoleit M; Kadivane S; Ouma C; Mubiru D; Mbusa B; Murangi A; Ejoku E; Rwantangle A; Kule U; Lule J; Garrett N; Halpin J; Maxwell N; Kagirita A; Mulabya F; Makumbi I; Freeman M; Joyce K; Hill V; Downing R; Mintz E
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2726. PubMed ID: 24603860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Typhoid fever vaccination strategies.
    Date KA; Bentsi-Enchill A; Marks F; Fox K
    Vaccine; 2015 Jun; 33 Suppl 3(Suppl 3):C55-61. PubMed ID: 25902360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Strategies and Incidence Thresholds for Vi Conjugate Vaccines Against Typhoid Fever: A Cost-effectiveness Modeling Study.
    Lo NC; Gupta R; Stanaway JD; Garrett DO; Bogoch II; Luby SP; Andrews JR
    J Infect Dis; 2018 Nov; 218(suppl_4):S232-S242. PubMed ID: 29444257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating investments in typhoid vaccines in two slums in Kolkata, India.
    Cook J; Sur D; Clemens J; Whittington D
    J Health Popul Nutr; 2009 Dec; 27(6):711-24. PubMed ID: 20099754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal, spatial and household dynamics of Typhoid fever in Kasese district, Uganda.
    Mirembe BB; Mazeri S; Callaby R; Nyakarahuka L; Kankya C; Muwonge A
    PLoS One; 2019; 14(4):e0214650. PubMed ID: 31009473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Strategies for Typhoid Conjugate Vaccine Introduction in India: A Cost-Effectiveness Modeling Study.
    Ryckman T; Karthikeyan AS; Kumar D; Cao Y; Kang G; Goldhaber-Fiebert JD; John J; Lo NC; Andrews JR
    J Infect Dis; 2021 Nov; 224(Supple 5):S612-S624. PubMed ID: 35238367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision Making and Implementation of the First Public Sector Introduction of Typhoid Conjugate Vaccine-Navi Mumbai, India, 2018.
    Date K; Shimpi R; Luby S; N R; Haldar P; Katkar A; Wannemuehler K; Mogasale V; Pallas S; Song D; Kunwar A; Loharikar A; Yewale V; Ahmed D; Horng L; Wilhelm E; Bahl S; Harvey P; Dutta S; Bhatnagar P
    Clin Infect Dis; 2020 Jul; 71(Suppl 2):S172-S178. PubMed ID: 32725235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance.
    Andrews JR; Baker S; Marks F; Alsan M; Garrett D; Gellin BG; Saha SK; Qamar FN; Yousafzai MT; Bogoch II; Antillon M; Pitzer VE; Kim JH; John J; Gauld J; Mogasale V; Ryan ET; Luby SP; Lo NC
    Lancet Infect Dis; 2019 Jan; 19(1):e26-e30. PubMed ID: 30170987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review of the Economic Evidence of Typhoid Fever and Typhoid Vaccines.
    Luthra K; Watts E; Debellut F; Pecenka C; Bar-Zeev N; Constenla D
    Clin Infect Dis; 2019 Mar; 68(Suppl 2):S83-S95. PubMed ID: 30845334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the costs of cholera illness and cost-effectiveness of a single dose oral vaccination campaign in Lusaka, Zambia.
    Tembo T; Simuyandi M; Chiyenu K; Sharma A; Chilyabanyama ON; Mbwili-Muleya C; Mazaba ML; Chilengi R
    PLoS One; 2019; 14(5):e0215972. PubMed ID: 31150406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness and public health impact of typhoid conjugate vaccine introduction strategies in Bangladesh.
    Weyant C; Hooda Y; Munira SJ; Lo NC; Ryckman T; Tanmoy AM; Kanon N; Seidman JC; Garrett D; Saha SK; Goldhaber-Fiebert JD; Saha S; Andrews JR
    Vaccine; 2024 Apr; 42(11):2867-2876. PubMed ID: 38531727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination against typhoid fever in travellers: a cost-effectiveness approach.
    Papadimitropoulos V; Vergidis PI; Bliziotis I; Falagas ME
    Clin Microbiol Infect; 2004 Aug; 10(8):681-3. PubMed ID: 15301670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A large outbreak of typhoid fever associated with a high rate of intestinal perforation in Kasese District, Uganda, 2008-2009.
    Neil KP; Sodha SV; Lukwago L; O-Tipo S; Mikoleit M; Simington SD; Mukobi P; Balinandi S; Majalija S; Ayers J; Kagirita A; Wefula E; Asiimwe F; Kweyamba V; Talkington D; Shieh WJ; Adem P; Batten BC; Zaki SR; Mintz E
    Clin Infect Dis; 2012 Apr; 54(8):1091-9. PubMed ID: 22357703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.